Centogene N.V., a commercial-stage company focused on rare diseases that transforms real-world clinical and genetic data into actionable information for patients, physicians, and pharmaceutical companies, provided an update on its corporate progress and reported its financial results for the three months ended March 31, 2020.
June 15, 2020
· 17 min read